Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

PatientConcept App: Key Characteristics, Implementation, and its Potential Benefit.

Lang M, Mayr M, Ringbauer S, Cepek L.

Neurol Ther. 2019 Jun;8(1):147-154. doi: 10.1007/s40120-019-0133-4. Epub 2019 Mar 26.

2.

Influence of the blood-CSF-barrier function on S100B in neurodegenerative diseases.

Steinacker P, Weidehaas K, Cepek L, Feneberg E, Kretzschmar HA, Otto M.

Acta Neurol Scand. 2013 Oct;128(4):249-56. doi: 10.1111/ane.12113. Epub 2013 Mar 19.

PMID:
23510454
3.

A proteomic approach for the diagnosis of bacterial meningitis.

Jesse S, Steinacker P, Lehnert S, Sdzuj M, Cepek L, Tumani H, Jahn O, Schmidt H, Otto M.

PLoS One. 2010 Apr 8;5(4):e10079. doi: 10.1371/journal.pone.0010079.

4.

Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease.

Jesse S, Steinacker P, Cepek L, von Arnim CA, Tumani H, Lehnert S, Kretzschmar HA, Baier M, Otto M.

J Alzheimers Dis. 2009;17(3):541-51. doi: 10.3233/JAD-2009-1075.

PMID:
19433893
5.

Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.

Brechlin P, Jahn O, Steinacker P, Cepek L, Kratzin H, Lehnert S, Jesse S, Mollenhauer B, Kretzschmar HA, Wiltfang J, Otto M.

Proteomics. 2008 Oct;8(20):4357-66. doi: 10.1002/pmic.200800375.

PMID:
18814332
6.

Gadolinium encephalopathy due to accidental intrathecal administration of gadopentetate dimeglumine.

Arlt S, Cepek L, Rustenbeck HH, Prange H, Reimers CD.

J Neurol. 2007 Jun;254(6):810-2. Epub 2007 Apr 2. No abstract available.

PMID:
17401744
7.

Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

Cepek L, Brechlin P, Steinacker P, Mollenhauer B, Klingebiel E, Bibl M, Kretzschmar HA, Wiltfang J, Otto M.

Dement Geriatr Cogn Disord. 2007;23(1):22-8. Epub 2006 Oct 26.

PMID:
17068393
8.
9.

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia.

Bibl M, Mollenhauer B, Esselmann H, Lewczuk P, Klafki HW, Sparbier K, Smirnov A, Cepek L, Trenkwalder C, Rüther E, Kornhuber J, Otto M, Wiltfang J.

Brain. 2006 May;129(Pt 5):1177-87. Epub 2006 Apr 6.

10.

Core hypothermia in multiple sclerosis: case report with magnetic resonance imaging localization of a thalamic lesion.

Linker RA, Mohr A, Cepek L, Gold R, Prange H.

Mult Scler. 2006 Feb;12(1):112-5.

PMID:
16459729
11.

Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.

Buerger K, Otto M, Teipel SJ, Zinkowski R, Blennow K, DeBernardis J, Kerkman D, Schröder J, Schönknecht P, Cepek L, McCulloch C, Möller HJ, Wiltfang J, Kretzschmar H, Hampel H.

Neurobiol Aging. 2006 Jan;27(1):10-5.

PMID:
16298235
12.

Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease.

Mollenhauer B, Bibl M, Trenkwalder C, Stiens G, Cepek L, Steinacker P, Ciesielczyk B, Neubert K, Wiltfang J, Kretzschmar HA, Poser S, Otto M.

J Neural Transm (Vienna). 2005 Jul;112(7):933-48. Epub 2004 Nov 24.

PMID:
15937638
13.

Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

Cepek L, Steinacker P, Mollenhauer B, Wiese B, Ciesielczyk B, Bibl M, Wiltfang J, Zerr I, Schulz-Schaeffer W, Kretzschmar HA, Poser S, Otto M.

Dement Geriatr Cogn Disord. 2005;19(5-6):376-82. Epub 2005 Mar 30.

PMID:
15802913
14.

Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies.

Mollenhauer B, Cepek L, Bibl M, Wiltfang J, Schulz-Schaeffer WJ, Ciesielczyk B, Neumann M, Steinacker P, Kretzschmar HA, Poser S, Trenkwalder C, Otto M.

Dement Geriatr Cogn Disord. 2005;19(2-3):164-70. Epub 2005 Jan 5.

PMID:
15637452
15.

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases.

Steinacker P, Mollenhauer B, Bibl M, Cepek L, Esselmann H, Brechlin P, Lewczuk P, Poser S, Kretzschmar HA, Wiltfang J, Trenkwalder C, Otto M.

Neurosci Lett. 2004 Nov 3;370(1):36-9.

PMID:
15489013
16.
17.

Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study.

Otto M, Cepek L, Ratzka P, Doehlinger S, Boekhoff I, Wiltfang J, Irle E, Pergande G, Ellers-Lenz B, Windl O, Kretzschmar HA, Poser S, Prange H.

Neurology. 2004 Mar 9;62(5):714-8.

PMID:
15007119
18.

CSF lactate dehydrogenase activity in patients with Creutzfeldt-Jakob disease exceeds that in other dementias.

Schmidt H, Otto M, Niedmann P, Cepek L, Schröter A, Kretzschmar HA, Poser S.

Dement Geriatr Cogn Disord. 2004;17(3):204-6. Epub 2004 Jan 20.

PMID:
14739545
19.

Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

Wiltfang J, Esselmann H, Smirnov A, Bibl M, Cepek L, Steinacker P, Mollenhauer B, Buerger K, Hampel H, Paul S, Neumann M, Maler M, Zerr I, Kornhuber J, Kretzschmar HA, Poser S, Otto M.

Ann Neurol. 2003 Aug;54(2):263-7.

PMID:
12891683
20.

Different binding pattern of antibodies to prion protein on lymphocytes from patients with sporadic Creutzfeldt-Jakob disease.

Ratzka P, Döhlinger S, Cepek L, Steinacker P, Arlt S, Jacobi C, Schröter A, Wiltfang J, Prange H, Kretzschmar HA, Poser S, Otto M.

Neurosci Lett. 2003 May 29;343(1):29-32.

PMID:
12749990
21.

Erythropoietin therapy for acute stroke is both safe and beneficial.

Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Rüther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Sirén AL.

Mol Med. 2002 Aug;8(8):495-505.

22.

Transcription of AML1/ETO in bone marrow and cord blood of individuals without acute myelogenous leukemia.

Basecke J, Cepek L, Mannhalter C, Krauter J, Hildenhagen S, Brittinger G, Trumper L, Griesinger F.

Blood. 2002 Sep 15;100(6):2267-8. No abstract available.

PMID:
12229881
23.

Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease.

Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, Steinacker P, Ciesielczyk B, Schulz-Schaeffer W, Kretzschmar HA, Poser S.

Neurology. 2002 Jan 22;58(2):192-7.

PMID:
11805244
24.

Serum tau protein level as a marker of axonal damage in acute ischemic stroke.

Bitsch A, Horn C, Kemmling Y, Seipelt M, Hellenbrand U, Stiefel M, Ciesielczyk B, Cepek L, Bahn E, Ratzka P, Prange H, Otto M.

Eur Neurol. 2002;47(1):45-51.

PMID:
11803192
25.

Unaltered apoptotic behaviour of mononuclear cells from patients with sporadic Creutzfeldt-Jakob disease.

Ratzka P, Schröter A, Cepek L, Henkel K, Wiltfang J, Kretzschmar HA, Prange H, Poser S, Otto M.

J Neurol. 2001 Aug;248(8):690-4.

PMID:
11569898
26.

Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

Otto M, Esselmann H, Schulz-Shaeffer W, Neumann M, Schröter A, Ratzka P, Cepek L, Zerr I, Steinacker P, Windl O, Kornhuber J, Kretzschmar HA, Poser S, Wiltfang J.

Neurology. 2000 Mar 14;54(5):1099-102.

PMID:
10720281
27.

[Fluorosis in Czechoslovakia].

CEPEK L, DANEK J, HANUSOVA S, PARMA C.

Cas Lek Cesk. 1950 Aug 11;89(32):883-9. Undetermined Language. No abstract available.

PMID:
14772820

Supplemental Content

Support Center